Latest news with #BruceFund
Yahoo
2 days ago
- Business
- Yahoo
Robert Bruce's Strategic Move: LyondellBasell Industries NV Takes Center Stage
Exploring the Latest 13F Filing and Investment Adjustments Robert Bruce (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights into his investment moves during this period. Robert Bruce (Trades, Portfolio) is the founder of Bruce & Co, the investment firm that serves as the advisor to the Bruce Fund (BRUFX). The Bruce Fund is run by Robert Bruce (Trades, Portfolio) and his son, Robert Jeffrey Bruce. The Fund focuses primarily on common stock investments, though it also invests in high-yield and distressed debt. It may invest in some long-term U.S. government securities if the managers cannot find attractive opportunities elsewhere. The Fund invests mostly in small- and mid-cap stocks, with the occasional large-cap, as well as convertible and distressed bonds. The Bruces tend to hold their stocks for the long-term, generally preferring the securities of distressed companies that are trading at a significant discount but which they believe can make a turnaround. Summary of New Buy Robert Bruce (Trades, Portfolio) added a total of 1 stock, among them: The most significant addition was LyondellBasell Industries NV (NYSE:LYB), with 40,000 shares, accounting for 0.75% of the portfolio and a total value of $2.31 million. Key Position Increases Robert Bruce (Trades, Portfolio) also increased stakes in a total of 2 stocks, among them: The most notable increase was Vicor Corp (NASDAQ:VICR), with an additional 20,000 shares, bringing the total to 90,000 shares. This adjustment represents a significant 28.57% increase in share count, a 0.3% impact on the current portfolio, with a total value of $4,082,400. The second largest increase was The Chemours Co (NYSE:CC), with an additional 50,000 shares, bringing the total to 250,000. This adjustment represents a significant 25% increase in share count, with a total value of $2,862,500. Summary of Sold Out Robert Bruce (Trades, Portfolio) completely exited 2 of the holdings in the second quarter of 2025, as detailed below: Organon & Co (NYSE:OGN): Robert Bruce (Trades, Portfolio) sold all 31,200 shares, resulting in a -0.15% impact on the portfolio. IGM Biosciences Inc (NASDAQ:IGMS): Robert Bruce (Trades, Portfolio) liquidated all 100,000 shares, causing a -0.04% impact on the portfolio. Key Position Reduces Robert Bruce (Trades, Portfolio) also reduced positions in 4 stocks. The most significant changes include: Reduced CMS Energy Corp (NYSE:CMS) by 30,000 shares, resulting in a -13.27% decrease in shares and a -0.73% impact on the portfolio. The stock traded at an average price of $71.31 during the quarter and has returned 6.67% over the past 3 months and 11.79% year-to-date. Reduced Merck & Co Inc (NYSE:MRK) by 10,000 shares, resulting in a -4.93% reduction in shares and a -0.29% impact on the portfolio. The stock traded at an average price of $79.65 during the quarter and has returned 13.43% over the past 3 months and -15.50% year-to-date. Portfolio Overview At the second quarter of 2025, Robert Bruce (Trades, Portfolio)'s portfolio included 40 stocks, with top holdings including 8.21% in Allstate Corp (NYSE:ALL), 7.98% in U-Haul Holding Co (NYSE:UHAL.B), 7.69% in AbbVie Inc (NYSE:ABBV), 7.1% in NextEra Energy Inc (NYSE:NEE), and 6.97% in AerCap Holdings NV (NYSE:AER). The holdings are mainly concentrated in 9 of all the 11 industries: Utilities, Healthcare, Industrials, Financial Services, Communication Services, Consumer Defensive, Technology, Basic Materials, and Energy. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus.
Yahoo
06-06-2025
- Business
- Yahoo
Is Bruce Fund (BRUFX) a Strong Mutual Fund Pick Right Now?
If you're looking for an Allocation Balanced fund category, then a potential option is Bruce Fund (BRUFX). BRUFX carries a Zacks Mutual Fund Rank of 3 (Hold), which is based on various forecasting factors like size, cost, and past performance. The world of Zacks' Allocation Balanced funds is an area filled with options, such as BRUFX. These funds like to invest in a variety of asset types, finding a balance between stocks, bonds, cash, and sometimes even precious metals and commodities; they are mostly categorized by their respective asset allocation. For investors, Allocation Balanced funds can provide an entry point into diversified mutual funds, and present core holding options for a portfolio of funds. Bruce is responsible for BRUFX, and the company is based out of Chicago, IL. Bruce Fund made its debut in October of 1983, and since then, BRUFX has accumulated about $345.79 million in assets, per the most up-to-date date available. The fund's current manager, R. Jeffrey Bruce, has been in charge of the fund since December of 1983. Of course, investors look for strong performance in funds. BRUFX has a 5-year annualized total return of 6.37% and is in the bottom third among its category peers. But if you are looking for a shorter time frame, it is also worth looking at its 3-year annualized total return of 1.97%, which places it in the bottom third during this time-frame. It is important to note that the product's returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund's [%] sale charge. If sales charges were included, total returns would have been lower. When looking at a fund's performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. The standard deviation of BRUFX over the past three years is 9.07% compared to the category average of 13.73%. Looking at the past 5 years, the fund's standard deviation is 10.41% compared to the category average of 13.37%. This makes the fund less volatile than its peers over the past half-decade. Investors should note that the fund has a 5-year beta of 0.5, so it is likely going to be less volatile than the market at large. Alpha is an additional metric to take into consideration, since it represents a portfolio's performance on a risk-adjusted basis relative to a benchmark, which in this case, is the S&P 500. With a negative alpha of -2.54, managers in this portfolio find it difficult to pick securities that generate better-than-benchmark returns. As competition heats up in the mutual fund market, costs become increasingly important. Compared to its otherwise identical counterpart, a low-cost product will be an outperformer, all other things being equal. Thus, taking a closer look at cost-related metrics is vital for investors. In terms of fees, BRUFX is a no load fund. It has an expense ratio of 0.65% compared to the category average of 0.91%. From a cost perspective, BRUFX is actually cheaper than its peers. While the minimum initial investment for the product is $1,000, investors should also note that each subsequent investment needs to be at least $500. Fees charged by investment advisors have not been taken into considiration. Returns would be less if those were included. Overall, Bruce Fund ( BRUFX ) has a neutral Zacks Mutual Fund rank, and in conjunction with its comparatively weak performance, average downside risk, and lower fees, this fund looks like a somewhat average choice for investors right now. Don't stop here for your research on Allocation Balanced funds. We also have plenty more on our site in order to help you find the best possible fund for your portfolio. Make sure to check out for more information about the world of funds, and feel free to compare BRUFX to its peers as well for additional information. And don't forget, Zacks has all of your needs covered on the equity side too! Make sure to check out for more information on our screening capabilities, Rank, and all our articles as well. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Get Your Free (BRUFX): Fund Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14-05-2025
- Business
- Yahoo
Robert Bruce's Strategic Moves: CMS Energy Corp Sees a -1.29% Portfolio Impact
Robert Bruce (Trades, Portfolio) recently submitted the 13F filing for the first quarter of 2025, providing insights into his investment moves during this period. Robert Bruce (Trades, Portfolio) is the founder of Bruce & Co, the investment firm that serves as the advisor to the Bruce Fund (BRUFX). The Bruce Fund is run by Robert Bruce (Trades, Portfolio) and his son, Robert Jeffrey Bruce. The Fund focuses primarily on common stock investments, though it also invests in high-yield and distressed debt. It may invest in some long-term U.S. government securities if the managers cannot find attractive opportunities elsewhere. The Fund invests mostly in small- and mid-cap stocks, with the occasional large-cap, as well as convertible and distressed bonds. The Bruces tend to hold their stocks for the long-term, generally preferring the securities of distressed companies that are trading at a significant discount but which they believe can make a turnaround. Warning! GuruFocus has detected 4 Warning Signs with UHAL.B. Robert Bruce (Trades, Portfolio) added a total of 2 stocks, among them: The most significant addition was The Chemours Co (NYSE:CC), with 200,000 shares, accounting for 0.87% of the portfolio and a total value of $2.706 million. The second largest addition to the portfolio was Venture Global Inc (NYSE:VG), consisting of 100,000 shares, representing approximately 0.33% of the portfolio, with a total value of $1.03 million. Robert Bruce (Trades, Portfolio) also increased stakes in a total of 2 stocks, among them: The most notable increase was AerCap Holdings NV (NYSE:AER), with an additional 33,500 shares, bringing the total to 183,500 shares. This adjustment represents a significant 22.33% increase in share count, a 1.1% impact on the current portfolio, with a total value of $18,748,200. The second largest increase was Fate Therapeutics Inc (NASDAQ:FATE), with an additional 200,000 shares, bringing the total to 550,000. This adjustment represents a significant 57.14% increase in share count, with a total value of $434,500. Robert Bruce (Trades, Portfolio) also reduced positions in 9 stocks. The most significant changes include: Reduced CMS Energy Corp (NYSE:CMS) by 60,000 shares, resulting in a -20.98% decrease in shares and a -1.29% impact on the portfolio. The stock traded at an average price of $69.84 during the quarter and has returned 0.87% over the past 3 months and 4.96% year-to-date. Reduced AT&T Inc (NYSE:T) by 100,000 shares, resulting in a -12.94% reduction in shares and a -0.73% impact on the portfolio. The stock traded at an average price of $25.15 during the quarter and has returned 3.38% over the past 3 months and 18.95% year-to-date. At the first quarter of 2025, Robert Bruce (Trades, Portfolio)'s portfolio included 41 stocks, with top holdings including 8.61% in U-Haul Holding Co (NYSE:UHAL.B), 8.6% in AbbVie Inc (NYSE:ABBV), 8.37% in Allstate Corp (NYSE:ALL), 7.19% in NextEra Energy Inc (NYSE:NEE), and 6.91% in Duke Energy Corp (NYSE:DUK). The holdings are mainly concentrated in 9 of all the 11 industries: Utilities, Healthcare, Industrials, Financial Services, Communication Services, Consumer Defensive, Technology, Basic Materials, and Energy. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
